|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00950 LEE'S PHARM
Nominal 
1.220 +0.020 (+1.667%) | 2023/12 - Final HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Net Cash from / (used in) Operating Activities | 110,082 | 283,634 | 210,683 | 218,911 | 399,953 |
| Net Cash from / (used in) Investing Activities | (145,218) | (256,053) | (370,282) | (523,742) | (261,411) |
| Net Cash from / (used in) Financing Activities | 13,439 | (128,596) | 60,974 | (9,804) | 323,792 |
| Increase / (Decrease) in Cash & Cash Equivalents | (21,697) | (101,015) | (98,625) | (314,635) | 462,334 |
| Cash & Cash Equivalents at beginning of period | 189,301 | 277,529 | 375,199 | 693,516 | 222,296 |
| Effect of Foreign Exchange Rate Changes | (76) | 12,787 | 955 | (3,682) | 8,886 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 167,528 | 189,301 | 277,529 | 375,199 | 693,516 |
| Remarks: | Real time quote last updated: 28/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 62,478,000 |
| %Change | 287.653% |
| EPS / (LPS) | HKD 0.106 |
| NBV Per Share ($) | HKD 2.910 |